A detailed history of Franklin Street Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Franklin Street Advisors Inc holds 4,744 shares of BMY stock, worth $279,279. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,744
Previous 9,946 52.3%
Holding current value
$279,279
Previous $413,000 40.68%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$39.66 - $51.75 $206,311 - $269,203
-5,202 Reduced 52.3%
4,744 $245,000
Q2 2024

Jul 18, 2024

BUY
$40.25 - $52.99 $14,127 - $18,599
351 Added 3.66%
9,946 $413,000
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $48,939 - $55,488
-1,020 Reduced 9.61%
9,595 $520,000
Q4 2023

Jan 18, 2024

SELL
$48.48 - $57.85 $24,240 - $28,925
-500 Reduced 4.5%
10,615 $545,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $23,156 - $25,892
400 Added 3.73%
11,115 $645,000
Q2 2023

Jul 13, 2023

BUY
$63.71 - $70.74 $20,642 - $22,919
324 Added 3.12%
10,715 $685,000
Q1 2023

Apr 12, 2023

SELL
$65.71 - $74.53 $10,185 - $11,552
-155 Reduced 1.47%
10,391 $720,000
Q4 2022

Feb 07, 2023

BUY
$68.48 - $81.09 $15,408 - $18,245
225 Added 2.18%
10,546 $759,000
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $33 - $19,978
-260 Reduced 2.46%
10,321 $734,000
Q2 2022

Jul 13, 2022

BUY
$72.62 - $79.98 $68,989 - $75,981
950 Added 9.86%
10,581 $815,000
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $30,837 - $35,949
-575 Reduced 5.63%
9,631 $600,000
Q3 2021

Oct 22, 2021

SELL
$59.17 - $69.31 $10,709 - $12,545
-181 Reduced 1.74%
10,206 $604,000
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $134,344 - $146,301
-2,170 Reduced 17.28%
10,387 $694,000
Q1 2021

May 04, 2021

SELL
$59.34 - $66.74 $509,315 - $572,829
-8,583 Reduced 40.6%
12,557 $793,000
Q4 2020

Feb 01, 2021

SELL
$57.74 - $65.43 $5.48 Million - $6.2 Million
-94,832 Reduced 81.77%
21,140 $1.31 Million
Q3 2020

Oct 21, 2020

SELL
$57.43 - $63.64 $3.75 Million - $4.16 Million
-65,329 Reduced 36.03%
115,972 $6.99 Million
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $419,537 - $490,480
-7,653 Reduced 4.05%
181,301 $10.7 Million
Q1 2020

Apr 16, 2020

SELL
$46.4 - $67.43 $2.1 Million - $3.04 Million
-45,151 Reduced 19.29%
188,954 $10.5 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $325,720 - $424,873
-6,619 Reduced 2.75%
234,105 $15 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $1.19 Million - $1.41 Million
27,731 Added 13.02%
240,724 $12.2 Million
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $1.63 Million - $1.81 Million
-36,642 Reduced 14.68%
212,993 $9.66 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $146,233 - $174,365
-3,241 Reduced 1.28%
249,635 $11.9 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $804,588 - $1.04 Million
-16,501 Reduced 6.13%
252,876 $13.1 Million
Q3 2018

Oct 05, 2018

SELL
$55.19 - $62.25 $40,840 - $46,065
-740 Reduced 0.27%
269,377 $16.7 Million
Q2 2018

Jul 16, 2018

BUY
$50.53 - $62.98 $1.6 Million - $1.99 Million
31,583 Added 13.24%
270,117 $14.9 Million
Q1 2018

Apr 11, 2018

BUY
$59.92 - $68.98 $7.43 Million - $8.55 Million
123,995 Added 108.26%
238,534 $15.1 Million
Q4 2017

Jan 10, 2018

BUY
$59.94 - $65.35 $232,027 - $252,969
3,871 Added 3.5%
114,539 $7.02 Million
Q3 2017

Oct 11, 2017

BUY
$55.23 - $63.74 $6.11 Million - $7.05 Million
110,668
110,668 $7.05 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.